The Net Margin of Abcellera Biologics Inc (ABCL) is -564.83%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -564.83% |
| 2023-12-31 | -385.00% |
| 2022-12-31 | 32.65% |
| 2021-12-31 | 40.91% |
| 2020-12-31 | 50.99% |
| 2019-12-31 | -18.97% |
| 2018-12-31 | 3.41% |